WHO ICTRP trial
Study of vitamin K2-7 (MK-7) in patients with tingling and numbness due to…
CTRI/2016/11/007499 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2016/11/007499 |
|---|---|
| Public title | Study of vitamin K2-7 (MK-7) in patients with tingling and numbness due to diabetes and / or vitamin B12 deficiency |
| Scientific title | An Open labeled Multicentre Trial to compare the safety and efficacy of Vitamin K2-7 (MK-7) in patients with peripheral neuropathy due to type 2 diabetes mellitus and/ or megaloblastic anaemia |
| Primary sponsor | Viridis BioPharma Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: null- Neuropathy occuring because of Megaloblastic Anaemia, Type 2 Diabetes Mellitus |
| Interventions | Intervention1: Vitamin K2-7 Capsules: Each capsule of 100 mcg to be given two times in a day orally after food for 8 weeks. Control Intervention1: NIL: NIL |
| Registration date | Nov 25, 2016 |
| Target size | 100 |
| Secondary IDs | VBPâ??VITAMIN K2-7 (MK-7)-PN /15 Ver 1 dt 6/6/2015 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: